Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

39.92
-0.7500-1.84%
Post-market: 40.000.0800+0.20%19:30 EDT
Volume:4.34M
Turnover:172.54M
Market Cap:95.65B
PE:21.41
High:40.07
Open:39.58
Low:39.50
Close:40.67
52wk High:52.68
52wk Low:39.50
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.18
T/O Rate:0.20%
Dividend:2.32
Dividend Rate:5.81%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.23
PE(LYR):10.62

Loading ...

Sanofi Opens New Flu Vaccine Facility in Toronto

MT Newswires Live
·
Sep 17

Sanofi inaugurates Canadian flu vaccine faclity

TIPRANKS
·
Sep 16

Sanofi to Acquire 26.4% Stake in Cheplapharm

MT Newswires Live
·
Sep 14

Sanofi, Cheplapharm enter strategic partnership

TIPRANKS
·
Sep 14

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Sep 09

Sanofi Will Need More Trials to Set New Asthma Drug Apart from Rival

Dow Jones
·
Sep 09

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

Arrowhead Pharmaceuticals' sHTG Therapy Could Get FDA Approval by Q2 2027, RBC Says

MT Newswires Live
·
Aug 31

Sanofi's Lunsekimig Needs to Deliver

Dow Jones
·
Aug 24

Sanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play

TIPRANKS
·
Aug 22

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11

Sanofi, Regeneron Seem Keen to Keep Working Together

Dow Jones
·
Aug 07

Sanofi Has Financial Muscle for Acquisitions

Dow Jones
·
Aug 07

Sanofi Submits New Application for Long-Acting RSV Antibody Treatment

Stock News
·
Aug 07

Sanofi Understands Its Problem, but Still Lacks Solutions

Dow Jones
·
Jul 31

Global Equities Roundup: Market Talk

Dow Jones
·
Jul 31

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D

Benzinga Earnings
·
Jul 31

Sanofi SA Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31